Karyopharm Therapeutics Balance Sheet (2012-2025) | KPTI

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	0.81M	141.31M	137.40M	6.35M	1.01M	82.25M	71.35M	1.06M	84.06M	0.57M	0.55M	52.23M	30.63M	84.77M	72.83M	62.48M	38.78M	34.90M	35.34M	47.73M
Short-term Investments (Quarter)	135.89M	94.58M	66.81M	38.16M	52.05M	88.60M	77.03M	142.78M	176.32M	155.87M	164.66M	139.21M	117.95M	67.35M	60.70M	46.24M	31.16M	12.97M	8.21M	3.20M
Cash & Current Investments (Quarter)	136.71M	235.89M	204.21M	44.51M	53.07M	170.85M	148.38M	143.84M	260.38M	156.44M	165.21M	191.44M	148.58M	152.12M	133.53M	108.71M	69.94M	47.88M	43.55M	50.94M
Receivables - Net (Quarter)	17.84M	17.89M	18.75M	22.50M	24.99M	23.48M	27.45M	47.09M	35.20M	32.28M	37.92M	26.96M	31.08M	37.99M	31.78M	30.77M	35.24M	32.93M	31.88M	26.18M
Receivables - Other (Quarter)
Receivables (Quarter)	17.84M	17.89M	18.75M	22.50M	24.99M	23.48M	27.45M	47.09M	35.20M	32.28M	37.92M	26.96M	31.08M	37.99M	31.78M	30.77M	35.24M	32.93M	31.88M	26.18M
Raw Materials (Quarter)	2.22M	1.82M	1.71M	1.80M	2.56M	0.26M	0.26M	1.37M	1.12M	1.12M	0.39M	0.55M	0.55M	0.72M	0.72M	0.72M	0.51M	0.48M	0.63M	0.63M
Work In Process (Quarter)	0.78M	1.86M	1.83M	1.90M	0.93M	2.87M	3.00M	1.88M	1.77M	1.70M	1.96M	1.73M	1.59M	2.15M	3.41M	3.54M	3.91M	4.17M	2.90M	2.98M
Finished Goods (Quarter)	0.11M	0.22M	0.40M	0.41M	0.39M	0.34M	0.99M	0.98M	0.94M	0.85M	0.76M	0.76M	0.63M	0.60M	0.54M	0.48M	0.35M	0.35M	0.43M	0.43M
Inventory (Quarter)	3.11M	3.90M	3.94M	4.11M	3.87M	3.47M	4.25M	4.22M	3.83M	3.67M	3.10M	3.04M	2.77M	3.48M	4.67M	4.74M	4.77M	4.99M	3.97M	4.04M
Prepaid Assets (Quarter)	9.37M	15.06M	12.27M	14.04M	29.14M	11.43M	31.47M	19.82M	18.28M	18.10M	13.33M	11.81M	15.48M	14.91M	14.75M	12.24M	10.29M	8.25M	8.03M	9.19M
Current Assets (Quarter)	255.51M	273.50M	241.58M	275.61M	276.53M	242.45M	222.68M	350.16M	318.54M	291.38M	263.22M	233.92M	198.37M	208.54M	184.75M	156.46M	120.24M	97.87M	89.75M	103.15M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	1.98M	1.75M	1.57M	1.64M	1.54M	1.40M	1.25M	1.14M	0.85M	0.77M	0.69M	0.61M	0.72M	0.63M	0.49M	0.40M	0.32M	0.24M	0.12M	0.10M
Long-Term Investments (Quarter)	7.68M	2.01M	2.00M
Other Non-Current Assets (Quarter)	0.72M	0.64M	0.64M	0.64M	0.64M	0.63M	0.63M	0.63M	0.63M	0.39M	0.38M	0.30M	0.30M	0.30M	0.31M	0.34M	1.33M	1.33M	1.33M	0.35M
Non-Current Assets (Quarter)	19.40M	13.06M	12.52M	29.70M	17.50M	14.03M	8.56M	8.01M	7.26M	6.45M	6.74M	6.52M	6.09M	5.44M	4.72M	7.96M	7.47M	7.01M	6.49M	5.27M
Assets (Quarter)	274.91M	286.57M	254.09M	305.31M	294.03M	256.48M	231.24M	358.17M	325.80M	297.83M	269.96M	240.44M	204.46M	213.98M	189.48M	164.42M	127.71M	104.88M	96.23M	108.42M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	3.04M	2.31M	0.88M	1.60M	3.44M	1.69M	0.81M	2.77M	9.04M	2.29M	0.94M	3.12M	5.03M	2.80M	5.78M	5.11M	5.87M	2.60M	5.39M	4.00M
Payables (Quarter)	3.04M	2.31M	0.88M	1.60M	3.44M	1.69M	0.81M	2.77M	9.04M	2.29M	0.94M	3.12M	5.03M	2.80M	5.78M	5.11M	5.87M	2.60M	5.39M	4.00M
Accumulated Expenses (Quarter)	55.61M	53.21M	64.70M	69.12M	58.37M	56.37M	55.72M	19.62M	47.03M	51.81M	55.71M	61.39M	54.85M	49.81M	50.10M	60.65M	57.17M	62.93M	66.33M	64.50M
Other Accumulated Expenses (Quarter)	1.36M	0.52M	1.12M	0.68M	2.06M	1.86M	2.46M	6.41M	2.50M	1.75M	2.23M	1.65M	2.04M	1.47M	1.94M	1.64M	1.94M	1.57M	1.76M	4.61M
Short term Debt (Quarter)																		6.25M	12.50M	21.01M
Current Leases (Quarter)	2.00M	2.08M	2.16M	2.32M	2.46M	2.62M	2.77M	2.87M	2.98M	3.08M	3.19M	3.31M	3.42M	3.54M	3.67M	0.44M	0.93M	1.38M	0.92M	0.97M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	62.01M	58.12M	68.87M	73.72M	66.34M	62.54M	61.76M	65.91M	61.55M	58.93M	62.08M	69.48M	65.34M	57.62M	61.49M	92.26M	90.37M	99.22M	87.16M	92.06M
Non-Current Liabilities
Non-Current Debt (Quarter)														93.52M	94.11M	94.60M	95.20M	89.57M	83.89M	94.80M
Convertible Debt (Quarter)	168.70M	168.90M	169.09M	169.29M	169.49M	169.69M	169.89M	170.10M	170.31M	170.50M	170.70M	170.92M	171.13M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
Non-Current Deferred Tax Liability (Quarter)
Operating Leases (Quarter)	10.75M	10.20M	9.63M	8.97M	8.29M	7.58M	6.86M	6.10M	5.31M	4.50M	3.67M	2.79M	1.88M	0.95M		6.71M	6.49M	6.25M	6.01M	5.74M
Other Non-Current Liabilities (Quarter)	73.09M	132.48M	132.48M	133.00M	133.00M	133.00M	133.00M	132.72M	1.08M	2.44M	132.48M	0.98M	2.58M	73.50M	73.50M	73.50M	73.50M	73.50M	14.12M	72.34M
Total Non-Current Liabilities (Quarter)	241.46M	237.22M	247.59M	251.98M	244.11M	239.82M	238.52M	242.11M	369.89M	366.64M	237.88M	375.67M	370.83M	272.62M	275.62M	276.94M	260.10M	270.31M	351.37M	329.00M
Total Liabilities (Quarter)	314.55M	369.70M	380.07M	384.98M	377.11M	372.82M	371.52M	374.83M	370.97M	369.08M	370.36M	376.64M	373.41M	346.12M	349.12M	350.44M	333.60M	343.81M	365.49M	401.34M
Shareholder's Equity
Total Debt (Quarter)														93.52M	94.11M	94.60M	95.20M	95.82M	96.39M	115.81M
Common Equity (Quarter)	-39.64M	-83.13M	-125.98M	-79.67M	-83.08M	-116.34M	-140.28M	-16.66M	-45.17M	-71.25M	-100.40M	-136.21M	-168.96M	-132.14M	-159.65M	-186.02M	-205.88M	-238.93M	-269.26M	-292.93M
Shareholder's Equity (Quarter)	-39.64M	-83.13M	-125.98M	-79.67M	-83.08M	-116.34M	-140.28M	-16.66M	-45.17M	-71.25M	-100.40M	-136.21M	-168.96M	-132.14M	-159.65M	-186.02M	-205.88M	-238.93M	-269.26M	-292.93M
Liabilities and Shareholders Equity (Quarter)	274.91M	286.57M	254.09M	305.31M	294.03M	256.48M	231.24M	358.17M	325.80M	297.83M	269.96M	240.44M	204.46M	213.98M	189.48M	164.42M	127.71M	104.88M	96.23M	108.42M
Retained Earnings (Quarter)	0.30M	-1165.56M	0.37M	-1178.65M	0.09M	-1269.11M	-1305.43M	-0.64M	-0.42M	-0.78M	-1445.20M	-0.16M	-1524.40M	-1500.61M	-1532.68M	-0.36M	-0.32M	-0.25M	-1657.30M	-1800.00M
Treasury Shares (Quarter)				2.30M				3.40M				7.67M				0.85M				1.32M

Research Tools

Karyopharm Therapeutics Balance Sheet (2012-2025) | KPTI

Create an account

Sign In

Reset Password